Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Timothy A. Yap(The University of Texas MD Anderson Cancer Center), Naval Daver(The University of Texas MD Anderson Cancer Center), Mikhila Mahendra(The University of Texas MD Anderson Cancer Center), Jixiang Zhang(The University of Texas MD Anderson Cancer Center), Carlos Kamiya-Matsuoka(The University of Texas MD Anderson Cancer Center), Funda Meric‐Bernstam(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Meghan Collins(The University of Texas at Austin), Maria Emilia Di Francesco(The University of Texas MD Anderson Cancer Center), Ecaterina E. Dumbrava(The University of Texas MD Anderson Cancer Center), Siqing Fu(The University of Texas MD Anderson Cancer Center), Sisi Gao(The University of Texas MD Anderson Cancer Center), Jason Gay(The University of Texas MD Anderson Cancer Center), Sonal Gera(The University of Texas MD Anderson Cancer Center), Jing Han(The University of Texas MD Anderson Cancer Center), David S. Hong(The University of Texas MD Anderson Cancer Center), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Zhenlin Ju(The University of Texas MD Anderson Cancer Center), Daniel D. Karp(The University of Texas MD Anderson Cancer Center), Alessia Lodi(The University of Texas at Austin), Jennifer R. Molina(The University of Texas MD Anderson Cancer Center), Natalia Baran(The University of Texas MD Anderson Cancer Center), Aung Naing(The University of Texas MD Anderson Cancer Center), Maro Ohanian(The University of Texas MD Anderson Cancer Center), Shubham Pant(The University of Texas MD Anderson Cancer Center), Naveen Pemmaraju(The University of Texas MD Anderson Cancer Center), Prithviraj Bose(The University of Texas MD Anderson Cancer Center), Sarina A. Piha‐Paul(The University of Texas MD Anderson Cancer Center), Jordi Rodón(The University of Texas MD Anderson Cancer Center), Carolina Salguero(The University of Texas MD Anderson Cancer Center), Koji Sasaki(The University of Texas MD Anderson Cancer Center), Anand Kumar Singh(The University of Texas MD Anderson Cancer Center), Vivek Subbiah(The University of Texas MD Anderson Cancer Center), Apostolia M. Tsimberidou(The University of Texas MD Anderson Cancer Center), Quanyun A. Xu(The University of Texas MD Anderson Cancer Center), Musa Yılmaz(The University of Texas MD Anderson Cancer Center), Qi Zhang(The University of Texas MD Anderson Cancer Center), Yuan Li(The University of Texas Health Science Center at Houston), Christopher A. Bristow(The University of Texas MD Anderson Cancer Center), Meenakshi B. Bhattacharjee(The University of Texas Health Science Center at Houston), Stefano Tiziani(Livestrong Foundation), Timothy P. Heffernan(The University of Texas MD Anderson Cancer Center), Christopher P. Vellano(The University of Texas MD Anderson Cancer Center), Philip Jones(The University of Texas MD Anderson Cancer Center), Cobi J. Heijnen(The University of Texas MD Anderson Cancer Center), Annemieke Kavelaars(The University of Texas MD Anderson Cancer Center), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), Marina Konopleva(The University of Texas MD Anderson Cancer Center)
Nature Medicine
January 1, 2023
Cited by 369

Abstract


Related Papers

No related papers found

Powered by citation graph analysis